Regencell Bioscience Holdings Ltd

NASDAQ RGC

Download Data

Regencell Bioscience Holdings Ltd Operating Income Per Share for the year ending June 30, 2023: -0.48

Regencell Bioscience Holdings Ltd Operating Income Per Share is -0.48 for the year ending June 30, 2023, a 17.64% change year over year. Operating income per share represents the amount of operating income generated by a company per outstanding share. It is calculated by dividing the operating income by the weighted average number of basic shares outstanding. This metric provides insights into the company's profitability from its core operations on a per-share basis. It is useful for evaluating the company's operational performance and comparing it with other companies on a per-share basis.
  • Regencell Bioscience Holdings Ltd Operating Income Per Share for the year ending June 30, 2022 was -0.59, a -435.76% change year over year.
  • Regencell Bioscience Holdings Ltd Operating Income Per Share for the year ending June 30, 2021 was -0.11, a -70.04% change year over year.
  • Regencell Bioscience Holdings Ltd Operating Income Per Share for the year ending June 30, 2020 was -0.06, a -107.77% change year over year.
  • Regencell Bioscience Holdings Ltd Operating Income Per Share for the year ending June 30, 2019 was -0.03, a -101.79% change year over year.
NASDAQ: RGC

Regencell Bioscience Holdings Ltd

CEO Mr. Yat-Gai Au
IPO Date July 16, 2021
Location Hong Kong
Headquarters First Commercial Building, Causeway Bay, Hong Kong
Employees 12
Sector Healthcare
Industry Drug manufacturers - specialty & generic
Description

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder, as well as infectious diseases. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Similar companies

EGRX

Eagle Pharmaceuticals Inc

NA

NA

PAHC

Phibro Animal Health Corporation

NA

NA

PROC

Procaps Group SA

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email